• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Financing › Details

Evotec–ROI Verwaltungsgesellschaft: investment, 201104 existent ROI owns 17.4m voting rights or 15.07% of voting rights

 

	Period	2011-04-20
	Money taker	Evotec AG
	Group	Evotec (Group)
	Product	drug discovery services
	Product 2	private equity
	Person	Oetker, Roland (ROI Verwaltungsgesellschaft mbH 200108 Managing Director + Founder)

Evotec AG. (4/20/11). "Press Release: Voting Rights. Publication Pursuant to §26 sect. 1 WPHG with the Aim of Pan-European Distribution [ROI Verwaltungsgesellschaft GmbH Owns 15.07%]". Hamburg.

Mr. Roland Oetker, Düsseldorf, Germany, has given notice pursuant to Sect. 21 para 1 WpHG that on April 18, 2011 his voting interest in Evotec AG exceeded the threshold of 15% and as of this day amounts to 15.07% (17,417,355 voting rights). Thereof voting rights of 15.07% (17,417,355) are attributed to him according to Section 22 para. 1 sentence 1 no. 1 WpHG via ROI Verwaltungsgesellschaft GmbH.

In addition, ROI Verwaltungsgesellschaft mbH, Düsseldorf, Germany, has given notice that on April 18, 2011 its voting interest in Evotec AG exceeded the threshold of 15% and as of this day amounts to 15.07% (17,417,355 voting rights).


Evotec AG
Schnackenburgallee 114
22525 Hamburg
Germany

--- End of Message ---

Record changed: 2011-11-25

More documents for Evotec (Group)

• [1] Evotec AG. (5/16/12). "Press Release: Evotec Becomes the First Contract Research Facility in Europe to Offer Agilent’s RapidFire/MS Screening for Pharmaceutical Drug Discovery". Hamburg....
• [2] Evotec AG. (6/24/11). "Press Release: Evotec and Roche to Jointly Develop Biomarkers in Oncology. An Alliance for Personalized Healthcare in Cancer Research and Development". Hamburg & Basel....
• [3] Evotec AG. (4/20/11). "Press Release: Voting Rights. Publication Pursuant to §26 sect. 1 WPHG with the Aim of Pan-European Distribution [ROI Verwaltungsgesellschaft GmbH Owns 15.07%]". Hamburg....
• [4] Evotec AG. (4/19/11). "Press Release: Acquisition of Kinaxo Biotechnologies GmbH Completed". Hamburg....
• [5] Evotec AG. (3/24/11). "Press Release: Full-Year 2010 Results. A Good Year with Strong Start into 2011". Hamburg....
• [6] Kinaxo Biotechnologies GmbH. (3/15/11). "Press Release: Kinaxo Extends Collaboration with Takeda". Martinsried....
• [7] Evotec AG. (2/9/11). "Press Release: Expanding Its Drug Discovery Platform with Cutting-edge Technologies. [Evotec AG Signs Definititive Agreement to Acquire All Shares in Kinaxo Biotechnologies GmbH]". Hamburg....
• [8] Kinaxo Biotechnologies GmbH. (1/5/11). "Press Release: Kinaxo Enters Agreement with AstraZeneca". Martinsried....
• [9] Kinaxo Biotechnologies GmbH. (10/11/10). "Press Release: Kinaxo Enters Agreement with Bristol-Myers Squibb Company". Martinsried....
• [10] Kinaxo Biotechnologies GmbH. (9/29/10). "Press Release: Kinaxo and Daiichi Sankyo Sign Collaboration Agreement". Martinsried....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.